Dublin, March 19, 2025 (GLOBE NEWSWIRE) — The “Pharmaceutical Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Small Molecule, Biologics), Drug, Service, Scale of Operation, Workflow, Application, End Use, Company, and Region with Growth Forecasts, 2025-2030” has been added to ResearchAndMarkets.com’s offering.
The Pharmaceutical Contract Manufacturing Market was valued at USD 129.19 billion in 2024, and is projected to reach USD 224.51 billion by 2030, rising at a CAGR of 9.84%. The market is anticipated to grow at a CAGR of 9.84% from 2025 to 2030.
Growth in the market can be attributed to benefits offered to pharmaceutical companies, such as cost efficiencies, the ability to leverage contract manufacturing facilities to streamline production, and the opportunity to focus on core competencies. In addition, the market is driven by the increasing demand for biologics, biosimilars, high-potency active pharmaceutical ingredients (HPAPIs), and personalized medicine.
The expansion of pharmaceutical companies into new product innovations has led to the increased demand for contract manufacturing organization (CMO) services for clinical trials, packaging, and regulatory compliance. Technological integrations among CMOs, such as continuous manufacturing, automation, and AI-driven process optimization, are further propelling pharmaceutical production. These innovations enhance efficiency, reduce waste, and improve product quality and standards.
The pharmaceutical contract manufacturing industry is expected to experience continued growth during the forecast period, as CMO providers play a crucial role in helping companies meet the regulatory requirements of the FDA, EMA, and ICH. Moreover, the growing demand for both branded and generic drugs is a significant factor in the expansion of the pharmaceutical contract manufacturing industry. As various generic drugs reach patent expiration, pharmaceutical companies are innovating new generic versions to meet this demand. Hence, many of these pharmaceutical companies are relying on CMO services to fulfill market needs efficiently and effectively.
In addition, regulation is one of the significant factors for pharmaceutical products that have fueled the demand for pharmaceutical contract manufacturing. The FDA plays a pivotal role in ensuring the safety and efficiency of pharmaceuticals in the market. Likewise, strategic partnerships and accelerating product launches drive market growth. For instance, in December 2024, Lonza mentioned the expansion of its service offering orally delivered biologic therapies to support innovative capsule companies’ unique development and manufacturing needs. The product launch will help patients explore innovative delivery solutions to mitigate bioavailability challenges.
Pharmaceutical Contract Manufacturing Market Report Highlights
- The API manufacturing segment dominated the market with a share of 70.68% in 2024. Growth in the segment can be attributed to increasing HPAPI production, rising demand for continuous API manufacturing, growing FDA approval for the market, and the launch of new products.
- Based on product, the small molecule segment held the largest market share in 2024, which is attributed to the increasing demand for generics, specialty drugs, and HPAPIs, and growing innovations of drugs have enhanced the requirement for CMO’s efficiency, scalability, and regulatory compliance further driving the market growth.
- The generics segment dominated the market in 2024 owing to the increasing prevalence of chronic diseases, growing patent expirations, and rising demand for cost-efficient drugs.
- Based on scale of operation, the batch segment dominated the market. It accounted for 88.88% in 2024, attributing to various benefits such as batch production and major support for saving operational costs.
- The commercial segment dominated the market in 2024. Growth in this segment can be attributed to the increasing launch of various products that help treat diseases.
- The oncology segment held the largest market share in 2024 based on application. This segment is driven by increasing cancer incidences and new pharmaceutical drug requirements.
- The pharmaceutical companies segment held the largest market share in 2024 based on end-use. Pharmaceutical companies utilize contract manufacturing to lower costs, increase scalability, and speed up time-to-market. CMOs offer expertise in API synthesis, formulation, and regulatory compliance. In addition, outsourcing provides access to advanced technologies, flexible production capacity, and optimized global supply chains.
- The small company size segment dominated the market in 2024 due to increasing employee strengths, facilities, and venture funding.
- Asia-Pacific is expected to register the fastest growth rate of 10.80% CAGR over the forecast period. Due to the rising number of pharmaceutical companies & contract manufacturing organizations in countries like Japan, China, and India, Asia-Pacific will likely witness rapid growth over the estimated time. Furthermore, the availability of a skilled workforce within the region at a lower cost compared to the U.S. is another factor that is anticipated to propel the market growth.
This report addresses:
- Market intelligence to enable effective decision-making.
- Market estimates and forecasts from 2018 to 2030.
- Growth opportunities and trend analyses.
- Segment and regional revenue forecasts for market assessment.
- Competition strategy and market share analysis.
- Product innovation listings for you to stay ahead of the curve.
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 150 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $129.19 Billion |
| Forecasted Market Value (USD) by 2030 | $224.51 Billion |
| Compound Annual Growth Rate | 9.8% |
| Regions Covered | Global |
Key Topics Covered
Chapter 1. Research Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Pharmaceutical Contract Manufacturing Market Variables, Trends & Scope
Chapter 4. Pharmaceutical Contract Manufacturing Market: Service Estimates & Trend Analysis
4.1. Pharmaceutical Contract Manufacturing Market, by Service: Segment Dashboard
4.2. Pharmaceutical Contract Manufacturing Market, by Service: Movement Analysis
4.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Service, 2018-2030
4.4. API Manufacturing
4.5. Finished Drug Product Manufacturing
4.6. Packaging Services
Chapter 5. Pharmaceutical Contract Manufacturing Market: Product Estimates & Trend Analysis
5.1. Pharmaceutical Contract Manufacturing Market, by Product: Segment Dashboard
5.2. Pharmaceutical Contract Manufacturing Market, by Product: Movement Analysis
5.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Product, 2018-2030
5.4. Small Molecule
5.5. Biologics
Chapter 6. Pharmaceutical Contract Manufacturing Market: Drug Estimates & Trend Analysis
6.1. Pharmaceutical Contract Manufacturing Market, by Drug: Segment Dashboard
6.2. Pharmaceutical Contract Manufacturing Market, by Drug: Movement Analysis
6.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Drug, 2018-2030
6.4. Generics
6.5. Branded
Chapter 7. Pharmaceutical Contract Manufacturing Market: Scale of Operation Estimates & Trend Analysis
7.1. Pharmaceutical Contract Manufacturing Market, by Scale of Operation: Segment Dashboard
7.2. Pharmaceutical Contract Manufacturing Market, by Scale of Operation: Movement Analysis
7.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Scale of Operation, 2018-2030
7.4. Batch
7.5. Continuous
Chapter 8. Pharmaceutical Contract Manufacturing Market: Workflow Estimates & Trend Analysis
8.1. Pharmaceutical Contract Manufacturing Market, by Workflow: Segment Dashboard
8.2. Pharmaceutical Contract Manufacturing Market, by Workflow: Movement Analysis
8.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Workflow, 2018-2030
8.4. Clinical
8.5. Commercial
Chapter 9. Pharmaceutical Contract Manufacturing Market: Application Estimates & Trend Analysis
9.1. Pharmaceutical Contract Manufacturing Market, by Application: Segment Dashboard
9.2. Pharmaceutical Contract Manufacturing Market, by Application: Movement Analysis
9.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Application, 2018-2030
9.4. Oncology
9.5. Infectious Diseases
9.6. Neurological Disorders
9.7. Cardiovascular Disease
9.8. Metabolic Disorders
9.9. Autoimmune Diseases
9.10. Respiratory Diseases
9.11. Ophthalmology
9.12. Gastrointestinal Disorders
9.13. Hormonal Disorders
9.14. Hematological Disorders
9.15. Others
Chapter 10. Pharmaceutical Contract Manufacturing Market: End Use Estimates & Trend Analysis
10.1. Pharmaceutical Contract Manufacturing Market, by End Use: Segment Dashboard
10.2. Pharmaceutical Contract Manufacturing Market, by End Use: Movement Analysis
10.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by End Use, 2018-2030
10.4. Pharmaceutical Companies
10.5. Biotechnology Companies
Chapter 11. Pharmaceutical Contract Manufacturing Market: Company Size Estimates & Trend Analysis
11.1. Pharmaceutical Contract Manufacturing Market, by Company Size: Segment Dashboard
11.2. Pharmaceutical Contract Manufacturing Market, by Company Size: Movement Analysis
11.3. Pharmaceutical Contract Manufacturing Market Estimates & Forecasts, by Company Size, 2018-2030
11.4. Small
11.5. Medium
11.6. Large
Chapter 12. Pharmaceutical Contract Manufacturing Market: Regional Estimates & Trend Analysis
12.1. Regional Market Share Analysis, 2024 & 2030
12.2. Regional Market Dashboard
12.3. Global Regional Market Snapshot
12.4. North America
12.5. Europe
12.6. Asia-Pacific
12.7. Latin America
12.8. MEA
Chapter 13. Competitive Landscape
13.1. Market Participant Categorization
13.2. Company Market Share Analysis, 2023/24
13.3. Company Profiles
13.3.1. AbbVie Contract Manufacturing
13.3.2. Almac Group
13.3.3. Boehringer Ingelheim BioXcellence
13.3.4. Catalent
13.3.5. Dr. Reddy’s Laboratories
13.3.6. Fareva
13.3.7. Fujifilm Diosynth Biotechnologies
13.3.8. Jubilant HollisterStier
13.3.9. Lonza Group
13.3.10. Patheon (Thermo Fisher Scientific)
13.3.11. Pfizer CentreOne
13.3.12. Prakruti Life Science
13.3.13. Recipharm
13.3.14. Samsung Biologics
13.3.15. Siegfried Holding AG
13.3.16. Vetter Pharma
13.3.17. WuXi AppTec
For more information about this report visit https://www.researchandmarkets.com/r/x07ktb
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Pharmaceutical Contract Manufacturing Market
